Yes, B has shown great promise from Absssi, OM, UP and now COV19. The main glaring concerns are how can a pipeline so promising be down to 6 million and 4 employees? Either the CEO has done a terrible job finding partners and financing or the hype surrounding the science has been misleading? Something has to give soon as Leo can’t play pretend biotech with limited staff and finances forever. Need other sources touting the science other than Leo’s inner circle of a few.